Visit the Caliper Life Sciences web site
Click on the advert above to visit the company web site

Product category: Contract research
News Release from: Chiltern International
Edited by the Laboratorytalk Editorial Team on 03 February 2004

New UK director of operations

Request your FREE weekly copy of the Laboratorytalk email newsletter. News about Contract research and more every issue. Click here for details.

Chiltern International appoints Ed Richards, formerly VP at PRA, as its UK director of operations

Chiltern International, which claims to be the largest privately held global CRO in the UK, has announced the appointment of Ed Richards as UK director of operations Before joining Chiltern, Richards was the vice president of UK operations for PRA International, building up its UK operation over a five-year period

Prior to that he worked in the pharmaceutical industry, initially for the American firm Cyanamid in both the UK and US, where he became director of its European Clinical Research Centre in Richmond, Surrey.

Following that he worked for Fujisawa in Munich, as head of biometrics.

He has a BSc and PhD from Imperial College, London, in chemistry, with specialism in statistical mechanics and thermodynamics.

He continued his research in physical chemistry with post-doctoral fellowships at McMaster University in Canada and Edinburgh University in Scotland.

Established in London in 1982, clinical research organisation Chiltern International provides clinical operations, project management, data management, biostatistics, medical writing, quality assurance and regulatory and medical affairs services to the pharmaceutical, biotechnology and medical device industries.

The company also offers clinical contract personnel services to pharmaceutical and biotechnology clients.

It has ten international offices - three in the United States and seven in Europe.

Commenting on his new role at Chiltern, Richards explained: "I'm very pleased to have joined Chiltern International at this exciting stage of its development.

"With the obvious high calibre of people involved in all parts of the organisation, the ability of the company to make very significant contributions to clinical development on behalf of our clients will continue to grow from an already firm base.".

Chiltern International: contact details and other news
Email this article to a colleague
Register for the free Laboratorytalk email newsletter
Laboratorytalk Home Page

Search the Pro-Talk network of sites

Visit the Caliper Life Sciences web site